Lim Hyun Kyong, Cho Jeong Yeon, Kim Seung Hyup
Department of Radiology, Seoul National University College of Medicine, 28, Yongon-dong, Chongno-gu, Seoul, 110-744, Republic of Korea.
Abdom Imaging. 2010 Aug;35(4):431-6. doi: 10.1007/s00261-009-9538-3. Epub 2009 May 22.
This study was designed to evaluate the long-term results of sclerotherapy for the treatment of peritoneal inclusion cysts (PICs).
Twenty-nine patients with 30 PICs were included in the study. Sclerotherapy was performed with use of povidone-iodine in 13 PICs and ethanol in 17 PICs, until the drained volume was less than 5 mL. Patients were evaluated after 1 month, 4 months, and then every 6 months by clinical assessment and ultrasound examination.
Sclerotherapy was technically successful for all 30 PICs. During the follow-up period of 7-94 months (mean: 38.0 months), the PICs completely disappeared in 15 lesions and the diameter of the cysts decreased more than 50% without symptoms for the other 12 lesions. The overall long-term success rate was 90.0% (27/30). There was no significant difference in the success rate between the use of povidone-iodine (92.3%, 12/13) and ethanol (88.2%, 15/17). Recurrence of a PIC occurred in three patients. Two PICs completely regressed without further recurrence after re-sclerotherapy. Remaining one was removed under surgery.
Sclerotherapy following catheter insertion is a safe, effective, and reliable method for the treatment of PICs. Long-term regular follow-up months may not be necessary.
本研究旨在评估硬化治疗腹膜包涵囊肿(PICs)的长期效果。
本研究纳入了29例患有30个PICs的患者。13个PICs使用聚维酮碘进行硬化治疗,17个PICs使用乙醇进行硬化治疗,直至引流量小于5 mL。在1个月、4个月后对患者进行评估,之后每6个月通过临床评估和超声检查进行评估。
30个PICs的硬化治疗在技术上均获成功。在7至94个月(平均38.0个月)的随访期内,15个病灶中的PICs完全消失,另外12个病灶的囊肿直径缩小超过50%且无症状。总体长期成功率为90.0%(27/30)。使用聚维酮碘(92.3%,12/13)和乙醇(88.2%,15/17)的成功率无显著差异。3例患者出现PICs复发。2个PICs在再次硬化治疗后完全消退且未进一步复发。剩下1个在手术中切除。
插管后硬化治疗是一种安全、有效且可靠的治疗PICs的方法。可能无需长期定期随访。